S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Sequencing questions and regional pharmacogenomics
Panel highlights unknowns about ADC sequencing, regional pharmacogenomics, and need for larger phase III comparisons.
Play episode from 26:52
Transcript
